Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Hardt-Lindberg S"'
Autor:
Scirica BM; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: bscirica@bwh.harvard.edu., Lincoff AM; Department of Cardiovascular Medicine, Cleveland Clinic and Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA., Lingvay I; Department of Internal Medicine/Endocrinology and Peter O'Donnell Jr School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Bogdanski P; Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Science, Poznan, Poland., Buscemi S; Department of Promozione della Salute, Materno-Infantile, Medicina Interna e Specialistica di Eccellenza, University of Palermo, Palermo, Italy; Unit of Clinical Nutrition, Obesity and Metabolic Diseases, University Hospital Policlinico 'P. Giaccone,' Palermo, Italy., Colhoun H; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, Scotland., Craciun AE; Department of Diabetes and Nutrition Diseases, Iuliu Hatieganu University of Medicine and Pharmacy Cluj-Napoca, Cluj, Romania; Department of Diabetes, Nutrition and Metabolic Diseases, Cluj County Hospital, Cluj, Romania., Ezhov M; National Cardiology Research Center, Moscow, Russia., Hardt-Lindberg S; Novo Nordisk A/S, Søborg, Denmark., Kleist Jeppesen O; Novo Nordisk A/S, Søborg, Denmark., Matos ALSA; Novo Nordisk A/S, Søborg, Denmark., Node K; Saga University, Saga, Japan., Schiele F; Université de Franche-Comté, SINERGIES, Besançon, France., Toplak H; Department of Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria., van Beek A; Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Weeke PE; Novo Nordisk A/S, Søborg, Denmark., Wiviott SD; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Deanfield J; Institute of Cardiovascular Science, University College London, London, United Kingdom., Ryan D; Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
Publikováno v:
Journal of the American College of Cardiology [J Am Coll Cardiol] 2024 Oct 22; Vol. 84 (17), pp. 1632-1642. Date of Electronic Publication: 2024 Aug 30.
Autor:
Deanfield J; Institute of Cardiovascular Sciences, University College London, London, UK. Electronic address: john.e.deanfield@gmail.com., Verma S; Division of Cardiac Surgery, Li Ka Shing Knowledge Institute of St Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, ON, Canada., Scirica BM; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Kahn SE; Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, WA, USA., Emerson SS; Department of Biostatistics, University of Washington, Seattle, WA, USA., Ryan D; Pennington Biomedical Research Center, Baton Rouge, LA, USA., Lingvay I; Department of Internal Medicine/Endocrinology and Peter O'Donnell Jr School of Public Health, UT Southwestern Medical Center, Dallas, TX, USA., Colhoun HM; Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Plutzky J; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Kosiborod MN; Department of Cardiovascular Disease, Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA., Hovingh GK; Novo Nordisk, Søborg, Denmark; Department of Vascular Medicine, Amsterdam University Medical Centers, Amsterdam, Netherlands., Hardt-Lindberg S; Novo Nordisk, Søborg, Denmark., Frenkel O; Novo Nordisk, Søborg, Denmark., Weeke PE; Novo Nordisk, Søborg, Denmark., Rasmussen S; Novo Nordisk, Søborg, Denmark., Goudev A; Department of Cardiology, Queen Giovanna University Hospital, Sofia, Bulgaria., Lang CC; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, UK., Urina-Triana M; Faculty of Health Sciences, Universidad Simón Bolívar, Barranquilla, Colombia., Pietilä M; Heart Center, Turku University Hospital, University of Turku, Turku, Finland., Lincoff AM; Department of Cardiovascular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Publikováno v:
Lancet (London, England) [Lancet] 2024 Aug 24; Vol. 404 (10454), pp. 773-786.
Autor:
Lincoff AM; From the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland (A.M.L.); Novo Nordisk, Søborg, Denmark (K.B.-F., S.E., S.H.-L., G.K.H., T.K.O., M.M.M., C.W.T.); the Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (H.M.C.), and the National Institute for Cardiovascular Outcomes Research, University College London, London (J.D.) - both in the United Kingdom; the Department of Biostatistics, University of Washington (S.S.E.), and the Department of Medicine, VA Puget Sound Health Care System and University of Washington (S.E.K.) - both in Seattle; the Department of Vascular Medicine, Academic Medical Center, Amsterdam (G.K.H.); the Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago (R.F.K.); the Department of Internal Medicine (Endocrinology Division) and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas (I.L.); the Department of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (J.P.); and Pennington Biomedical Research Center, Baton Rouge, LA (D.H.R.)., Brown-Frandsen K; From the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland (A.M.L.); Novo Nordisk, Søborg, Denmark (K.B.-F., S.E., S.H.-L., G.K.H., T.K.O., M.M.M., C.W.T.); the Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (H.M.C.), and the National Institute for Cardiovascular Outcomes Research, University College London, London (J.D.) - both in the United Kingdom; the Department of Biostatistics, University of Washington (S.S.E.), and the Department of Medicine, VA Puget Sound Health Care System and University of Washington (S.E.K.) - both in Seattle; the Department of Vascular Medicine, Academic Medical Center, Amsterdam (G.K.H.); the Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago (R.F.K.); the Department of Internal Medicine (Endocrinology Division) and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas (I.L.); the Department of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (J.P.); and Pennington Biomedical Research Center, Baton Rouge, LA (D.H.R.)., Colhoun HM; From the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland (A.M.L.); Novo Nordisk, Søborg, Denmark (K.B.-F., S.E., S.H.-L., G.K.H., T.K.O., M.M.M., C.W.T.); the Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (H.M.C.), and the National Institute for Cardiovascular Outcomes Research, University College London, London (J.D.) - both in the United Kingdom; the Department of Biostatistics, University of Washington (S.S.E.), and the Department of Medicine, VA Puget Sound Health Care System and University of Washington (S.E.K.) - both in Seattle; the Department of Vascular Medicine, Academic Medical Center, Amsterdam (G.K.H.); the Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago (R.F.K.); the Department of Internal Medicine (Endocrinology Division) and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas (I.L.); the Department of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (J.P.); and Pennington Biomedical Research Center, Baton Rouge, LA (D.H.R.)., Deanfield J; From the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland (A.M.L.); Novo Nordisk, Søborg, Denmark (K.B.-F., S.E., S.H.-L., G.K.H., T.K.O., M.M.M., C.W.T.); the Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (H.M.C.), and the National Institute for Cardiovascular Outcomes Research, University College London, London (J.D.) - both in the United Kingdom; the Department of Biostatistics, University of Washington (S.S.E.), and the Department of Medicine, VA Puget Sound Health Care System and University of Washington (S.E.K.) - both in Seattle; the Department of Vascular Medicine, Academic Medical Center, Amsterdam (G.K.H.); the Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago (R.F.K.); the Department of Internal Medicine (Endocrinology Division) and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas (I.L.); the Department of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (J.P.); and Pennington Biomedical Research Center, Baton Rouge, LA (D.H.R.)., Emerson SS; From the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland (A.M.L.); Novo Nordisk, Søborg, Denmark (K.B.-F., S.E., S.H.-L., G.K.H., T.K.O., M.M.M., C.W.T.); the Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (H.M.C.), and the National Institute for Cardiovascular Outcomes Research, University College London, London (J.D.) - both in the United Kingdom; the Department of Biostatistics, University of Washington (S.S.E.), and the Department of Medicine, VA Puget Sound Health Care System and University of Washington (S.E.K.) - both in Seattle; the Department of Vascular Medicine, Academic Medical Center, Amsterdam (G.K.H.); the Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago (R.F.K.); the Department of Internal Medicine (Endocrinology Division) and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas (I.L.); the Department of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (J.P.); and Pennington Biomedical Research Center, Baton Rouge, LA (D.H.R.)., Esbjerg S; From the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland (A.M.L.); Novo Nordisk, Søborg, Denmark (K.B.-F., S.E., S.H.-L., G.K.H., T.K.O., M.M.M., C.W.T.); the Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (H.M.C.), and the National Institute for Cardiovascular Outcomes Research, University College London, London (J.D.) - both in the United Kingdom; the Department of Biostatistics, University of Washington (S.S.E.), and the Department of Medicine, VA Puget Sound Health Care System and University of Washington (S.E.K.) - both in Seattle; the Department of Vascular Medicine, Academic Medical Center, Amsterdam (G.K.H.); the Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago (R.F.K.); the Department of Internal Medicine (Endocrinology Division) and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas (I.L.); the Department of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (J.P.); and Pennington Biomedical Research Center, Baton Rouge, LA (D.H.R.)., Hardt-Lindberg S; From the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland (A.M.L.); Novo Nordisk, Søborg, Denmark (K.B.-F., S.E., S.H.-L., G.K.H., T.K.O., M.M.M., C.W.T.); the Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (H.M.C.), and the National Institute for Cardiovascular Outcomes Research, University College London, London (J.D.) - both in the United Kingdom; the Department of Biostatistics, University of Washington (S.S.E.), and the Department of Medicine, VA Puget Sound Health Care System and University of Washington (S.E.K.) - both in Seattle; the Department of Vascular Medicine, Academic Medical Center, Amsterdam (G.K.H.); the Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago (R.F.K.); the Department of Internal Medicine (Endocrinology Division) and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas (I.L.); the Department of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (J.P.); and Pennington Biomedical Research Center, Baton Rouge, LA (D.H.R.)., Hovingh GK; From the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland (A.M.L.); Novo Nordisk, Søborg, Denmark (K.B.-F., S.E., S.H.-L., G.K.H., T.K.O., M.M.M., C.W.T.); the Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (H.M.C.), and the National Institute for Cardiovascular Outcomes Research, University College London, London (J.D.) - both in the United Kingdom; the Department of Biostatistics, University of Washington (S.S.E.), and the Department of Medicine, VA Puget Sound Health Care System and University of Washington (S.E.K.) - both in Seattle; the Department of Vascular Medicine, Academic Medical Center, Amsterdam (G.K.H.); the Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago (R.F.K.); the Department of Internal Medicine (Endocrinology Division) and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas (I.L.); the Department of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (J.P.); and Pennington Biomedical Research Center, Baton Rouge, LA (D.H.R.)., Kahn SE; From the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland (A.M.L.); Novo Nordisk, Søborg, Denmark (K.B.-F., S.E., S.H.-L., G.K.H., T.K.O., M.M.M., C.W.T.); the Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (H.M.C.), and the National Institute for Cardiovascular Outcomes Research, University College London, London (J.D.) - both in the United Kingdom; the Department of Biostatistics, University of Washington (S.S.E.), and the Department of Medicine, VA Puget Sound Health Care System and University of Washington (S.E.K.) - both in Seattle; the Department of Vascular Medicine, Academic Medical Center, Amsterdam (G.K.H.); the Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago (R.F.K.); the Department of Internal Medicine (Endocrinology Division) and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas (I.L.); the Department of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (J.P.); and Pennington Biomedical Research Center, Baton Rouge, LA (D.H.R.)., Kushner RF; From the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland (A.M.L.); Novo Nordisk, Søborg, Denmark (K.B.-F., S.E., S.H.-L., G.K.H., T.K.O., M.M.M., C.W.T.); the Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (H.M.C.), and the National Institute for Cardiovascular Outcomes Research, University College London, London (J.D.) - both in the United Kingdom; the Department of Biostatistics, University of Washington (S.S.E.), and the Department of Medicine, VA Puget Sound Health Care System and University of Washington (S.E.K.) - both in Seattle; the Department of Vascular Medicine, Academic Medical Center, Amsterdam (G.K.H.); the Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago (R.F.K.); the Department of Internal Medicine (Endocrinology Division) and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas (I.L.); the Department of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (J.P.); and Pennington Biomedical Research Center, Baton Rouge, LA (D.H.R.)., Lingvay I; From the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland (A.M.L.); Novo Nordisk, Søborg, Denmark (K.B.-F., S.E., S.H.-L., G.K.H., T.K.O., M.M.M., C.W.T.); the Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (H.M.C.), and the National Institute for Cardiovascular Outcomes Research, University College London, London (J.D.) - both in the United Kingdom; the Department of Biostatistics, University of Washington (S.S.E.), and the Department of Medicine, VA Puget Sound Health Care System and University of Washington (S.E.K.) - both in Seattle; the Department of Vascular Medicine, Academic Medical Center, Amsterdam (G.K.H.); the Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago (R.F.K.); the Department of Internal Medicine (Endocrinology Division) and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas (I.L.); the Department of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (J.P.); and Pennington Biomedical Research Center, Baton Rouge, LA (D.H.R.)., Oral TK; From the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland (A.M.L.); Novo Nordisk, Søborg, Denmark (K.B.-F., S.E., S.H.-L., G.K.H., T.K.O., M.M.M., C.W.T.); the Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (H.M.C.), and the National Institute for Cardiovascular Outcomes Research, University College London, London (J.D.) - both in the United Kingdom; the Department of Biostatistics, University of Washington (S.S.E.), and the Department of Medicine, VA Puget Sound Health Care System and University of Washington (S.E.K.) - both in Seattle; the Department of Vascular Medicine, Academic Medical Center, Amsterdam (G.K.H.); the Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago (R.F.K.); the Department of Internal Medicine (Endocrinology Division) and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas (I.L.); the Department of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (J.P.); and Pennington Biomedical Research Center, Baton Rouge, LA (D.H.R.)., Michelsen MM; From the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland (A.M.L.); Novo Nordisk, Søborg, Denmark (K.B.-F., S.E., S.H.-L., G.K.H., T.K.O., M.M.M., C.W.T.); the Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (H.M.C.), and the National Institute for Cardiovascular Outcomes Research, University College London, London (J.D.) - both in the United Kingdom; the Department of Biostatistics, University of Washington (S.S.E.), and the Department of Medicine, VA Puget Sound Health Care System and University of Washington (S.E.K.) - both in Seattle; the Department of Vascular Medicine, Academic Medical Center, Amsterdam (G.K.H.); the Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago (R.F.K.); the Department of Internal Medicine (Endocrinology Division) and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas (I.L.); the Department of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (J.P.); and Pennington Biomedical Research Center, Baton Rouge, LA (D.H.R.)., Plutzky J; From the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland (A.M.L.); Novo Nordisk, Søborg, Denmark (K.B.-F., S.E., S.H.-L., G.K.H., T.K.O., M.M.M., C.W.T.); the Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (H.M.C.), and the National Institute for Cardiovascular Outcomes Research, University College London, London (J.D.) - both in the United Kingdom; the Department of Biostatistics, University of Washington (S.S.E.), and the Department of Medicine, VA Puget Sound Health Care System and University of Washington (S.E.K.) - both in Seattle; the Department of Vascular Medicine, Academic Medical Center, Amsterdam (G.K.H.); the Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago (R.F.K.); the Department of Internal Medicine (Endocrinology Division) and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas (I.L.); the Department of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (J.P.); and Pennington Biomedical Research Center, Baton Rouge, LA (D.H.R.)., Tornøe CW; From the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland (A.M.L.); Novo Nordisk, Søborg, Denmark (K.B.-F., S.E., S.H.-L., G.K.H., T.K.O., M.M.M., C.W.T.); the Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (H.M.C.), and the National Institute for Cardiovascular Outcomes Research, University College London, London (J.D.) - both in the United Kingdom; the Department of Biostatistics, University of Washington (S.S.E.), and the Department of Medicine, VA Puget Sound Health Care System and University of Washington (S.E.K.) - both in Seattle; the Department of Vascular Medicine, Academic Medical Center, Amsterdam (G.K.H.); the Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago (R.F.K.); the Department of Internal Medicine (Endocrinology Division) and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas (I.L.); the Department of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (J.P.); and Pennington Biomedical Research Center, Baton Rouge, LA (D.H.R.)., Ryan DH; From the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland (A.M.L.); Novo Nordisk, Søborg, Denmark (K.B.-F., S.E., S.H.-L., G.K.H., T.K.O., M.M.M., C.W.T.); the Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (H.M.C.), and the National Institute for Cardiovascular Outcomes Research, University College London, London (J.D.) - both in the United Kingdom; the Department of Biostatistics, University of Washington (S.S.E.), and the Department of Medicine, VA Puget Sound Health Care System and University of Washington (S.E.K.) - both in Seattle; the Department of Vascular Medicine, Academic Medical Center, Amsterdam (G.K.H.); the Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago (R.F.K.); the Department of Internal Medicine (Endocrinology Division) and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas (I.L.); the Department of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (J.P.); and Pennington Biomedical Research Center, Baton Rouge, LA (D.H.R.).
Publikováno v:
The New England journal of medicine [N Engl J Med] 2023 Dec 14; Vol. 389 (24), pp. 2221-2232. Date of Electronic Publication: 2023 Nov 11.
Autor:
Lingvay I; Department of Internal Medicine/Endocrinology and Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, Texas, USA., Brown-Frandsen K; Novo Nordisk A/S, Søborg, Denmark., Colhoun HM; Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Deanfield J; Farr Institute of Health Informatics Research at London, London, UK and National Institute for Cardiovascular Outcomes Research, University College London, London, UK., Emerson SS; Department of Biostatistics, University of Washington, Seattle, Washington, USA., Esbjerg S; Novo Nordisk A/S, Søborg, Denmark., Hardt-Lindberg S; Novo Nordisk A/S, Søborg, Denmark., Hovingh GK; Novo Nordisk A/S, Søborg, Denmark., Kahn SE; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington, USA., Kushner RF; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Lincoff AM; Cleveland Clinic Coordinating Center for Clinical Research (C5Research) and Department of Cardiovascular Medicine, Cleveland, Ohio, USA., Marso SP; HCA Midwest Health Heart and Vascular Institute, Kansas City, Missouri, USA., Fries TM; Novo Nordisk A/S, Søborg, Denmark., Plutzky J; Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ryan DH; Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana, USA.
Publikováno v:
Obesity (Silver Spring, Md.) [Obesity (Silver Spring)] 2023 Jan; Vol. 31 (1), pp. 111-122. Date of Electronic Publication: 2022 Dec 10.
Autor:
Sawami, Kosuke1,2 (AUTHOR), Tanaka, Atsushi2 (AUTHOR) tanakaa2@cc.saga-u.ac.jp, Node, Koichi2 (AUTHOR)
Publikováno v:
Cardiovascular Diabetology. 11/15/2024, Vol. 23 Issue 1, p1-11. 11p.
Autor:
Quagliariello, Vincenzo1 (AUTHOR) martina.iovine@istitutotumori.na.it, Canale, Maria Laura2 (AUTHOR) marialaura.canale@uslnordovest.toscana.it, Bisceglia, Irma3 (AUTHOR) irmabisceglia@gmail.com, Iovine, Martina1 (AUTHOR) vienna.giordano@istitutotumori.na.it, Giordano, Vienna1 (AUTHOR) ilaria.giacobbe@istitutotumori.na.it, Giacobbe, Ilaria1 (AUTHOR) matteo.barbato@istitutotumori.na.it, Scherillo, Marino4 (AUTHOR) marino.scherillo@libero.it, Gabrielli, Domenico5 (AUTHOR) dgabrielli@scamilloforlanini.rm.it, Maurea, Carlo6 (AUTHOR) carlo.maurea@libero.it, Barbato, Matteo1 (AUTHOR) n.maurea@istitutotumori.na.it, Inno, Alessandro7 (AUTHOR) alessandro.inno@sacrocuore.it, Berretta, Massimiliano8 (AUTHOR) berrettama@gmail.com, Tedeschi, Andrea9 (AUTHOR) andrea.tedeschimd@gmail.com, Oliva, Stefano10 (AUTHOR) s.oliva@oncologico.bari.it, Greco, Alessandra11 (AUTHOR) a.greco@smatteo.pv.it, Maurea, Nicola1 (AUTHOR)
Publikováno v:
International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 20, p11299. 16p.
Autor:
Bellos, Ioannis1,2 (AUTHOR) bellosg@windowslive.com, Lagiou, Pagona1 (AUTHOR), Benetou, Vassiliki1 (AUTHOR), Marinaki, Smaragdi2 (AUTHOR)
Publikováno v:
Journal of Clinical Medicine. Oct2024, Vol. 13 Issue 20, p6181. 17p.
Autor:
Salmen, Teodor1 (AUTHOR) claudia-gabriela.potcovaru@drd.umfcd.ro, Potcovaru, Claudia-Gabriela1 (AUTHOR) ioana-cristina.bica@drd.umfcd.ro, Bica, Ioana-Cristina1 (AUTHOR) roxana-adriana.stoica@drd.umfcd.ro, Giglio, Rosaria Vincenza2,3 (AUTHOR) rosariavincenza.giglio@unipa.it, Patti, Angelo Maria4 (AUTHOR) pattiangelomaria@gmail.com, Stoica, Roxana-Adriana1 (AUTHOR), Ciaccio, Marcello2,3 (AUTHOR) marcello.ciaccio@unipa.it, El-Tanani, Mohamed5 (AUTHOR) eltanani@rakmhsu.ac.ae, Janež, Andrej6 (AUTHOR) andrej.janez@kclj.si, Rizzo, Manfredi5,7 (AUTHOR) manfredi.rizzo@unipa.it, Gherghiceanu, Florentina8 (AUTHOR) f.gherghiceanu@umfcd.ro, Stoian, Anca Pantea9 (AUTHOR) anca.stoian@umfcd.ro
Publikováno v:
Pharmaceuticals (14248247). Oct2024, Vol. 17 Issue 10, p1322. 15p.
Autor:
Rodríguez-Miguel, Antonio1 (AUTHOR) antonio.rodriguezmig@uah.es, Fernández-Fernández, Beatriz2,3,4 (AUTHOR) bfernandez@fjd.es, Ortiz, Alberto2,3,4 (AUTHOR) aortiz@fjd.es, Gil, Miguel5 (AUTHOR), Rodríguez-Martín, Sara1 (AUTHOR), Ruiz-Hurtado, Gema6,7,8 (AUTHOR) gemaruiz@h12o.es, Fernández-Antón, Encarnación1,9 (AUTHOR), Ruilope, Luis M.6,8,10 (AUTHOR), de Abajo, Francisco J.1,9 (AUTHOR) francisco.abajo@uah.es
Publikováno v:
Pharmaceuticals (14248247). Oct2024, Vol. 17 Issue 10, p1299. 15p.
Autor:
Prentza, Vasiliki1 (AUTHOR) prentzavasiliki@gmail.com, Pavlidis, George1 (AUTHOR) geo_pavlidis@yahoo.gr, Ikonomidis, Ignatios1 (AUTHOR) lampsas.stam@gmail.com, Pililis, Sotirios2 (AUTHOR) sotiris181@yahoo.gr, Lampsas, Stamatios1 (AUTHOR) johnythg@gmail.com, Kountouri, Aikaterini2 (AUTHOR) katerinak90@hotmail.com, Pliouta, Loukia2 (AUTHOR) plioutaloukia@gmail.com, Korakas, Emmanouil2 (AUTHOR) mankor-th@hotmail.com, Thymis, John1 (AUTHOR), Palaiodimou, Lina3 (AUTHOR) tsivgoulisgiorg@yahoo.gr, Tsegka, Aikaterini2 (AUTHOR) tsegka@gmail.com, Markakis, Konstantinos2 (AUTHOR) kmark2105@gmail.com, Halvatsiotis, Panagiotis2 (AUTHOR) pahalv@gmail.com, Tsivgoulis, Georgios3 (AUTHOR), Lambadiari, Vaia2 (AUTHOR) vlambad@otenet.gr
Publikováno v:
Journal of Clinical Medicine. Oct2024, Vol. 13 Issue 19, p5786. 16p.